The male-specific lethal (MSL) complex upregulates the single male X chromosome to achieve dosage compensation in Drosophila melanogaster. We have proposed that MSL recognition of specific entry sites on the X is followed by local targeting of active genes marked by histone H3 trimethylation (H3K36me3). Here we analyze the role of the MSL3 chromodomain in the second targeting step. Using ChIP-chip analysis, we find that MSL3 chromodomain mutants retain binding to chromatin entry sites but show a clear disruption in the full pattern of MSL targeting in vivo, consistent with a loss of spreading. Furthermore, when compared to wild type, chromodomain mutants lack preferential affinity for nucleosomes containing H3K36me3 in vitro. Our results support a model in which activating complexes, similarly to their silencing counterparts, use the nucleosomal binding specificity of their respective chromodomains to spread from initiation sites to flanking chromatin. Dosage compensation is an essential chromatin-mediated process in D. melanogaster, required in males to upregulate the single X chromosome by twofold to match the gene expression levels from the two X chromosomes in females. At least five proteins and two noncoding roX RNAs are members of the MSL complex, which acetylates histone H4 at lysine 16 (H4K16ac). It has been known for some time that the MSL complex specifically targets the polytene X chromosome at hundreds of sites in a reproducible, banded pattern, but the rules that govern specific targeting are only recently becoming evident with the application of high-resolution approaches such as chromatin immunoprecipitation combined with microarray analysis (ChIP-chip).
Dosage compensation is an essential chromatin-mediated process in D. melanogaster, required in males to upregulate the single X chromosome by twofold to match the gene expression levels from the two X chromosomes in females. At least five proteins and two noncoding roX RNAs are members of the MSL complex, which acetylates histone H4 at lysine 16 (H4K16ac). It has been known for some time that the MSL complex specifically targets the polytene X chromosome at hundreds of sites in a reproducible, banded pattern, but the rules that govern specific targeting are only recently becoming evident with the application of high-resolution approaches such as chromatin immunoprecipitation combined with microarray analysis (ChIP-chip).
Drosophila melanogaster MSL3 is a conserved protein containing an N-terminal chromodomain 1, 2 . In the absence of MSL3, partial MSL complexes can target only a subset of sites on X, termed high-affinity or chromatin entry sites (CES), originally mapped at the cytological level to approximately 35-70 locations [3] [4] [5] [6] . Initial targeting of entry sites is thought to provide the X-chromosome specificity of dosage compensation. In a two-step model, this is followed by spreading of the MSL complex in cis to active genes, independently of sequence. Full targeting correlates with the 3¢-biased H3K36me3 general mark on active genes, and is diminished in set2 mutants, which lack the enzyme responsible for this mark, providing evidence for a sequence-independent mechanism [7] [8] [9] . Alternatively, secondary sites may be recognized through DNA sequences of lesser affinities acting cooperatively 6, [10] [11] [12] [13] [14] , but such sequences have yet to be defined or mutated to demonstrate function.
The concept of sequence-independent spreading is further supported by the identification of ectopic binding sites seen when a roX2 transgene is inserted on an autosome 8 . In the absence of a roX gene in cis, autosomes would never normally be targeted by the MSL complex. However, when the MSL complex is ectopically localized on autosomes, flanking secondary sites show the same characteristics of typical targets seen on the X, correlating with a 3¢ enrichment of H3K36me3 on active genes. Formally, it is still possible that there is a sequence component to 3¢ recognition, but if so, it is not specific to X-chromosomal genes.
The concept of spreading rests on a foundation of observations from the study of gene silencing and heterochromatin. The idea originated from the discovery and analysis of position-effect variegation in D. melanogaster 15, 16 . The molecular mechanism of spreading is most clearly defined by the study of silencing of mating-type genes in Schizosaccharomyces pombe, where the chromodomain proteins Swi6 and Clr4 have prominent roles 17, 18 . Likewise, the founding chromodomain proteins heterochromatin protein-1 (HP1) and Polycomb both function in repressive complexes in D. melanogaster that are implicated in creating silent domains 19, 20 . We previously demonstrated that formation of the complete MSL pattern on the X was dependent on MSL3 and H3K36me3, providing a circumstantial case for the involvement of the MSL3 chromodomain in spreading of the dosage-compensation complex 3, 8 . Yet, the chromodomain of MSL3 has been mutated and deemed dispensable for MSL targeting at the cytological level 21 . Here, by high-resolution ChIP-chip, we show that MSL3 chromodomain mutants in D. melanogaster actually fail to bind most genes on the X chromosome. Our results support a model in which initial sequence-specific targeting of chromatin entry sites is followed by spreading in cis, mediated predominantly by the MSL3 chromodomain.
RESULTS

Developmental delay of MSL3 chromodomain mutant males
To study the contribution of the MSL3 chromodomain to targeting of the dosage compensation complex, we created transgenic lines expressing a deletion of the domain, as well as a set of targeted point mutants in potential methyllysine binding aromatic residues identified by alignment with other chromodomains 22, 23 . The mutants were constructed in the context of a wild-type transgene fused to the tandem affinity purification (TAP) epitope tag, driven by the endogenous msl3 promoter (Fig. 1a) . We created the chromodomain deletion (DCD) by mutating the start codon for full-length MSL3, which ablated its expression and led to overproduction of a naturally occurring short form that initiated at Met127, downstream of the chromodomain. The peptide composition of the short form was confirmed by TAP-tag affinity purification followed by mass spectrometry (Supplementary Methods and Fig. 1 online) . The site-directed mutants designed to disrupt chromodomain function altered the following residues: (i) Tyr31 along with its neighboring residues Leu30 and Thr32 to alanine residues to obtain the LYT30A mutant; (ii) Tyr63 along with Ser62 and Asp64 to alanine residues, resulting in the SYD62A mutant; and (iii) Trp59 to glycine to create the W59G mutant (Fig. 1a) .
We inserted all mutant transgenes, as well as the wild-type construct, into the same genomic location on chromosome 2L (55C-D) using the FC31-mediated attB/attP sitespecific recombination system to avoid position effects on transgene expression 24 . To assess the function of the mutants, we scored the ability of these transgenes to rescue msl3 1 mutant males (Fig. 1b) . The wild-type construct could rescue msl3 1 mutant males efficiently (97%). It was previously shown that an msl3 mutant partially deleted for the chromodomain was subviable, with only 7% of mutant males reaching adulthood 21 . We observed higher viability for our DCD construct: roughly half of the mutant males (53%) survived into adulthood, with the rest dying as late pupae. Although viable, all DCD mutant males were developmentally delayed by 2 d (compared with their heterozygous brothers carrying the msl3 + TM3 balancer chromosome), with phenotypes such as held-out wings. Adult males were unhealthy and infertile. We observed similar results with two of the chromodomain missense mutants, SYD62A and W59G. Their mutant rescue was 62% and 77%, respectively, and mutant males were developmentally delayed by 2 d. In contrast, the LYT30A mutant failed to complement msl3 1 . The lack of a functional chromodomain in MSL3 might lead to lower levels of stable MSL complex; if this were the case, it would be difficult to assign a specific function to the conserved motif. Therefore, we performed western analysis of males expressing the transgenes in the absence of endogenous msl3 to determine the levels of the MSL3-TAP mutant proteins. The expression of the LYT30A mutant was assessed in an msl3 + background, as these males are inviable. Consistent with its inability to rescue msl3 1 , the LYT30A mutant protein seemed to be highly unstable, and thus was deemed uninformative (Fig. 1c) . In contrast, we found that the W59G, SYD62A and DCD mutant proteins were expressed at levels comparable to wild-type MSL3. To assay for complex assembly, we affinity purified the W59G, SYD62A and DCD mutant proteins from cell lysates using the TAP epitope, and in each case, we could detect co-immunoprecipitation of MSL1 and Males absent on the first (MOF) by western analysis (Fig. 1d) . Although this was a qualitative rather than a quantitative assessment, the result is in agreement with previous studies, in which an intact MRG domain preserved functional interactions with the other components of the MSL complex, even in the absence of the chromodomain 25 .
ChIP-chip analysis of chromodomain mutant binding Polytene-chromosome binding patterns of the DCD, SYD62A and W59G mutant proteins on the X chromosome were indistinguishable from that of the wild type (Fig. 1e) . This was previously the basis for the conclusion that MSL targeting was normal in the absence of the MSL3 chromodomain 21 . However, we reasoned that differences in binding might be seen only at the level of chromatin immunoprecipitation (ChIP), as observed for MSL binding in a set2 mutant 8 .
Immunostaining of polytene chromosomes cannot distinguish between association with single sites and binding to multiple, tightly clustered genes. Therefore, we performed ChIP-chip analysis using a mixed population of msl3 1 mutant male and msl3 + female embryos expressing the wild-type, DCD or SYD62A constructs (see Methods for crosses). As females lack MSL2 and hence do not have functional MSL complexes 26 , they do not contribute positively to the ChIP signal. We performed ChIP using the TAP epitope to immunoprecipitate chromatin fragments bound by the wild-type, DCD and SYD62A proteins and characterized the resulting DNA on our previously described custom Nimblegen tiling arrays, which cover the entire euchromatic X chromosome and the left arm of chromosome 2 as a negative control 7 (388,000 Â 50-mer probes tiled at a resolution of 100 base pair (bp)). We performed each experiment in duplicate for each genotype and used the signal intensities from both profiles to calculate a mean signal intensity value for each probe on the array. A computational algorithm was applied to locate statistically significant clusters of binding, assessing the minimum level of enrichment and the size of each cluster (Methods). We then calculated the total number of bound clusters for each genotype and determined the number of bound genes within the clusters. Using these criteria, wild-type MSL3-TAP protein bound to 1,337 genes within 694 clusters on the X, and 9 clusters were bound on chromosome arm 2L. Chromodomain mutants retained a strong bias for the X but bound to only a subset of the wild-type targets. We mapped 340 genes within 338 clusters in the SYD62A mutant (with 13 clusters on 2L) and 432 genes within 444 clusters in the DCD mutant (with 15 clusters on 2L). Therefore, at least twothirds of wild-type target genes were scored as unbound in the SYD62A and DCD mutants (Fig. 2a) . The clusters in chromodomain mutants were also smaller and contained fewer genes on average than clusters in the wild type (B1.0 gene per cluster for SYD62A or DCD; B1.9 genes per cluster for wild type).
What characterizes the chromodomain-independent genes on the X? One possibility is that those are the genes that show the highest occupancy or signal for the wild-type complex. When we plotted histograms of MSL3 occupancy (that is, signal intensities from the wild-type ChIP-chip experiment) over each gene on the X, we found that the genes bound by the chromodomain mutants do fall within the region of high signal (Fig. 2b) . To exclude the possibility that the smaller amount of binding observed in the MSL3 mutants was a consequence of experimental or statistical procedure, we compared the signal intensity of each probe in the wild type (x axis) to its intensity in the DCD experiment (y axis) (Fig. 2c) . If the signal on one array is simply a muted version of the signal on the other array, the probe values should be scattered along a single line. Instead, we see that there are two separate probe clusters. This clearly shows that only a specific subclass of probes remains bound by the DCD mutant rather than a general decrease across all probes.
MSL3 chromodomain mutants retain entry site binding
Notably, when individual ChIP-chip profiles of chromodomain mutant binding sites are compared to those of the wild type, they show graphically what might be expected for the initial recognition sites of the MSL complex: discrete peaks of binding instead of coverage of whole genes and neighboring genes (Fig. 3a) . Noting the pattern, we wondered whether the discrete peaks might reflect binding to chromatin entry sites, with a loss of spreading to cover whole genes and flanking targets. Chromatin entry sites were originally defined as the 35-70 sites seen on the polytene chromosomes of msl3 mutant larvae. However, we recently proposed that this was an underestimate on the basis of ChIP-chip experiments of msl3 1 mutant embryos, in which we identified a set of at least 150 candidate entry sites containing a GA-or TC-rich MSL-recognition element (MRE) required for MSL binding 27 . Therefore, we examined whether the B400 binding sites detected in our chromodomain mutants included the 150 newly defined entry sites. We found that 98% of the entry sites were contained within the SYD62A and DCD sets of binding clusters. Furthermore, when we searched for B8-25 bp motifs using the MEME algorithm 28 , the top sequence identified using 500-bp peaks from either SYD62A or DCD clusters was a GA-rich motif that aligns extremely well with the MRE 27 (Fig. 3b) . However, not all DCD sites have MREs. When we surveyed 500-bp segments centered on the peaks within SYD62A or DCD clusters, B190 sites in both cases contain an MRE at a P-value of 10 À5 . Using a 1-kb window, the number of such sites rose to B240; further increasing the window size had minimal effect. This indicates that a substantial number of binding sites in chromodomain mutants (up to 200) do not encompass an MRE. These sites generally gave a lower signal in our mutant ChIP-chip analysis (data not shown). Therefore, we wondered whether Figure 2a .
For this plot, we defined the signal for a gene as the maximum log ratio over the gene. (c) Scatter plot of ChIP-chip signals between wild type and DCD at probe level. If the probe is equally bound in both wild-type and DCD experiments, the representative point should fall near the diagonal. The presence of two separate clusters of red probes on the X suggests that there are two types of bound sites in the wild type: chromodomain-independent (cluster 1) and chromodomain-dependent sites (cluster 2).
these additional binding sites might be the result of a limited amount of spreading retained in the chromodomain mutants.
To investigate this, we probed the spatial relationship between the 150 chromatin entry sites defined previously 27 and the additional sites bound by the SYD62A and DCD mutants. We computed the distribution of the distances of bound probes to their nearest entry site in the wild type and in each chromodomain mutant (Fig. 3c,d ). This analysis indicated that spreading in the wild type may generally occur within 5-10 kb on either side of an entry site, roughly corresponding to the size of an interband or a thin band on polytene chromosomes 29 . In contrast, binding in the SYD62A and DCD mutants clustered almost exclusively around the 150 entry sites previously identified. Although the two mutants differed in the absolute number of binding sites that scored as positive in the ChIP-chip experiments, the distribution of those sites shows that the mutants have similar profiles that differ substantially from the wild-type profile. In the mutants, the number of bound probes fell sharply at distances past 1 kb on either side of the proposed entry sites (Fig. 3c,d) , suggesting an appreciable reduction in spreading.
Although this analysis showed a clear difference between the mutants and the wild type in the extent of MSL binding at a distance from the entry sites, the differences between the wild-type and chromodomain mutant patterns disappear when plotted at 30-kb resolution, as most MSL binding sites are clustered within a few kilobases of an entry site (Fig. 3e) . This explains the previous inability to detect differences in immunostaining at the level of polytene chromosomes 21 . We conclude that chromodomain mutants recognize a defined set of entry sites through the MRE motif, with a limited amount of additional binding that may represent local (o2 kb) spreading in cis.
MSL3 chromodomain mutants are defective in spreading
To further probe the ability of the SYD62A and DCD proteins to direct spreading, we asked whether expression of the mutant proteins might 5′  25  24  23  22  21  20  19  18  17  16  15  14  13  12  11  10  9  8  7  6  5  4  3 visibly interfere with the extensive wild-type spreading seen from an autosomal roX transgene insertion on polytene chromosomes. Using a transgenic line carrying a GMroX2 transgene at 26D8, which shows extensive spreading in the absence of roX1 and roX2 genes on the X 8 ( Fig. 4a) , we analyzed the behavior of the mutant proteins and their effects on wild-type complexes in a dominant assay with one functional copy of the endogenous wild-type msl3 + gene present. When stained for the TAP epitope, transgenic wild-type MSL3 showed consistent and extensive spreading around the roX2 insertion in close to 100% of nuclei, as expected (Fig. 4b) . However, the chromodomain mutants failed to do so, to varying extents. In msl3 1 heterozygotes carrying a DCD transgene, about half of all nuclei showed spreading of both MSL3-TAP and MSL2, albeit not as extensively as the wild-type control (Fig. 4c) . The remaining nuclei did not show any spreading for either MSL3-TAP or MSL2, although both proteins were detected at the transgene-insertion site. In the W59G point mutant, most nuclei showed spreading for MSL3-TAP and MSL2 (Fig. 4d) . The most pronounced defect was observed in the SYD62A mutant, where almost all nuclei lacked spreading for both MSL3-TAP and MSL2, even though wild-type MSL3 protein was present (Fig. 4e) . Therefore, chromodomain mutant proteins can interfere with ectopic spreading of endogenous MSL complexes, even in the presence of wild-type MSL3. This argues against a model in which simply lowering the level of complex results in the loss of binding seen in DCD mutants. Rather, the lack of an intact chromodomain is specifically implicated in diminished spreading from entry sites.
Defective H3K36me3 binding by MSL3 chromodomain mutants
How does the MSL3 chromodomain mediate local spreading? One possibility is that it binds to a specific histone mark. MSL3 homologs in yeast (Eaf3) and humans (MRG15) have been implicated in H3K36me3 interaction via their chromodomains 22, [30] [31] [32] . Recombinant wild-type MSL3 binds nucleosomes with a preference for methylated H3K36 in vitro 8 ; thus, the MSL3 chromodomain is clearly a strong candidate to mediate this interaction. To specifically address this possibility, we purified TAP-tagged recombinant wild-type, DCD, SYD62A and W59G proteins using the baculovirus expression system and tested them for binding to nucleosomes using in vitro gelshift assays.
When tested for binding to methylated H3K36, wild-type protein shows increased binding to modified nucleosomes versus those that were unmodified (Fig. 5a, comparing lane 14 to lane 4) , consistent with previous data that MSL3 has a higher affinity for nucleosomes with H3K36 methylation 8 . The SYD62A and the W59G mutants showed no difference in binding to methylated versus unmodified nucleosomes, suggesting that the protein's general affinity for nucleosomes was retained, but specificity for methylated H3K36 is lost in these mutants (Fig. 5a) . The DCD recombinant protein lacked even general binding to nucleosomes (Fig. 5b) , as reported previously 21 . These data demonstrate that recombinant MSL3 recognizes nucleosomes via its chromodomain, with increased affinity for octamers containing the methylated H3K36 mark.
In the simplest model, absence of the MSL3 chromodomain or lack of the H3K36me3 mark would result in similar MSL binding profiles, with retention of initial binding at entry sites but a defect in subsequent spreading. The inviability of set2 mutants precluded collection of sufficient material for comparative ChIP-chip analysis of the effects on spreading in this background 8 . However, the individual target genes previously characterized as requiring the Set2 H3K36 methyltransferase for optimal MSL binding 8 were also chromodomain dependent in our current study (binding to seven of eight genes was strongly reduced, Supplementary Fig. 2 online) . Furthermore, apparent spreading in the wild type clearly correlated with the H3K36me3 mark surrounding entry sites (see Fig. 3a for an example).
The hypothesis that H3K36me3 functions in spreading led us to ask whether chromatin entry sites might be more likely to be located in regions of the genome enriched for this mark. We found that this is indeed the case 27 (Fig. 5c) . When X-chromosome locations with potential MREs are characterized with respect to the average density of the H3K36me3 mark, it is clear that MREs in regions with a higher H3K36me3 signal are the most likely to fall within functional entry sites (Fig. 5c) . Together, these data further support a model in which the MSL3 chromodomain mediates MSL spreading through association with the H3K36me3 mark.
DISCUSSION
In this study, we provide evidence that the initial targeting and spreading aspects of the MSL complex are separable steps required to achieve the final MSL binding pattern on the X chromosome, and that spreading is mediated by the MSL3 chromodomain. By making stable but functionally defective MSL3 mutants, we were able to uncouple these two activities and study them individually.
By comparing ChIP-chip data obtained from wild-type and MSL3 chromodomain mutants, we identified two classes of target genes on the X: a chromodomain-independent group (B25% of all targets) and a larger, chromodomain-dependent group (B75% of all targets). The chromodomain-independent group encompasses a larger set of chromatin entry sites than originally postulated from analyses of polytene chromosomes in msl3-null mutants. The difference could be related to a reduction in overall MSL complex levels when MSL3 protein is completely absent. Thus, it is possible that there is an entry site within most active gene clusters (Fig. 3e) . If spreading of the MSL complex is generally a short-range phenomenon (Fig. 3c) , this could also explain why the complex seems to fail to spread at the cytological level into autosomal fragments inserted on the X and vice versa 10, 11 . Having hundreds rather than a more limited set of initiation sites would make D. melanogaster dosage compensation targeting more similar to the Caenorhabditis elegans model than previously suspected 33, 34 .
The data presented here are summarized in a two-step model for targeting of the MSL complex to the X chromosome (Fig. 6 ). In this model, there are two classes of MSL target genes on the X: sequencedependent entry sites and chromodomain-dependent active genes. Initially, the MSL complex recognizes specific MREs within entry sites on the X chromosome, leading to local acetylation of nearby targets 27, 35 . The local acetylation at these sites is sufficient for marginal survival, and this step is independent of the MSL3 chromodomain. In a second step, the MSL3 chromodomain directs the complex to more distant genes by recognizing H3K36-methylated nucleosomes (Fig. 6a) , probably in conjunction with general DNA and nucleosomal binding 21, 25 . Whether the MSL complex actually traverses intergenic regions or releases and reattaches to nearby active genes is not known. Furthermore, chromodomain defects may lead to secondary effects on spreading through other MSL subunits, although our nucleosomal binding analysis using recombinant MSL3 protein strongly suggests a direct effect. Regardless, in the absence of the MSL3 chromodomain, the spreading step is defective (Fig. 6b) . How far the complex will travel without the chromodomain may depend on the local MSL concentration at the nearest entry site.
This work, together with a large body of gene-silencing literature, suggests an important parallel between principles for organizing chromatin into active and silent domains. Groups studying the mechanism of heterochromatin initiation and propagation have long embraced the spreading concept, although it has been less evident that similar mechanisms function to organize active chromatin. In the field of D. melanogaster dosage compensation, the spreading idea continues to be debated. Here we show that the chromodomain can be an important facilitator for the establishment of an upregulated, active chromatin state. Our results support a genomic organization model in which chromodomains are key components for the establishment of both active and silent chromatin domains. 
METHODS
Fly genetics and transgenesis. We carried out mutagenesis using a derivative of Invitrogen's GATEWAY entry vector pENTR TM 4, containing a 6-kb BamHI msl3-tap fragment (pENTR4-MSL3-TAP), and the Stratagene XL mutagenesis kit. Primers used for mutagenesis are available upon request. We constructed the pGreeni-RfA-attB destination vector using an enhanced green fluorescent protein (EGFP) gene driven in the eye by the Pax6 promoter 36 , the Gateway RfA recombination cassette containing a ccdB and a chloramphenicol resistance gene, and the 293-bp phiC31 attB sequence. The RfA cassette was exchanged with MSL3-TAP derivatives from pENTR4-MSL3-TAP by LR recombination (Invitrogen).
We created transgenic flies using fC31 integrase-mediated attB/attP recombination. We performed injections as described previously 24 : 200 ng ml -1 of each pGreeni plasmid containing attB and msl3-tap was mixed with 0.5 mg ml -1 fC31 integrase mRNA, and injected into fly embryos carrying the attP1 docking site on chromosome 2R. mRNA for the integrase gene was synthesized using the mMessage mMachine kit (Ambion) after linearization of 1 mg of pET11phiC31 (ref. 24) . We identified transgenics by eye-specific GFP expression. Transgenics were crossed to msl3 1 mutants to establish stocks. For complementation, we crossed homozygous msl3 1 mutant virgins (y w; msl3 1 /msl3 1 ) to transgenic males heterozygous for msl3 1 (y w; attP1 y+{p[gfp+ MSL3TAP-pGreeni]}; msl3 1 / TM3,Sb) and calculated the rescue rates by dividing the number of rescued males by the number of their TM3-balanced brothers. The genotype of rescued males was y w; attP1 y+{p[gfp+ MSL3-TAP-WT-pGreeni]}/+ ; msl3 1 / msl3 1 with MSL3-TAP-WT replaced with DCD, SYD62A, W59G or LYT30A for the mutants.
We performed polytene chromosome immunostaining as previously described 27, 37 . The primary antibodies used were affinity purified anti-MSL2 and anti-MSL3 at 1:500 dilution and anti-PAP antibody (Sigma) at 1:250 dilution. The secondary antibodies used were anti-mouse AlexaFluor594 (1:500) and anti-goat AlexaFluor488 (Invitrogen). Hoechst dye (Invitrogen) was used to stain DNA (1:10,000). To test general cross-reactivity of the Protein A moiety of the TAP tag to antibodies, we performed immunostaining with various alternative primary and secondary antibodies, but only the anti-PAP antibody (Sigma) gave positive results.
Characterization of MSL3-TAP complexes in Schneider cells. We performed transfections of 10 mg of pGreeni-MSL3-TAP plasmids using the Calcium Phosphate Transfection Kit (Invitrogen). We co-transfected 1 mg of plasmid encoding the hygromycin-resistance gene (pCoHygro) to select for stable transformant growth in Schneider Drosophila Medium (Gibco) containing 300 mg ml -1 hygromycin (Invitrogen). We performed TAP purification from whole-cell extracts as described previously 27, 36, 37 , using 5 mg of total protein for each pull down. We performed western blots using the following primary antibodies: rabbit anti-MSL1 (1:2.000); rabbit anti-MOF (1:5,000); goat anti-MSL3 (1:3,000); mouse anti-tubulin (1:10,000; Sigma); and rabbit anti-PAP (1:2,000; Sigma). Horseradish peroxidase (HRP)-conjugated secondary antibodies and the Dura kit were used for visualization (Pierce).
Chromatin preparation and ChIP-chip analysis. We prepared chromatin from embryos as described previously 7 . For a single experiment, we collected 0.5 g of 12-17 hour-old mixed-sex embryos from wild-type, MSL3-TAP, DCD and SYD62A mutants from the following crosses: we crossed homozygous virgin mothers carrying the MSL3-TAP transgene on the second chromosome in a homozygous msl3 1 mutant background (y w; attP1 y+{p[gfp+ MSL3-TAPpGreeni]}; msl3 1 ) to msl3 1 mutant males carrying a wild-type msl3 + cosmid on their X chromosome (y w p[cos8-1-msl3 + ]; +; msl3 1 ). Male progeny inherit the Y chromosome from their fathers rather than the msl3 + cosmid and thus are dependent on their respective MSL3-TAP transgenes for function. Females inherit the msl3 + cosmid but lack functional MSL complexes because of femalespecific translational repression of MSL2. We performed ChIP using the TAP tag as described previously 37 . The resulting amplified input and immunoprecipitated DNA were labeled and hybridized to custom microarrays by NimbleGen Systems as described previously 7 .
We performed two replicates for each genotype. For each two-channel Nimblegen array (ChIP versus input), we corrected for dye-specific bias from the average intensity versus log ratio plot using a combination of rotation and curve fitting 38 . We computed the noise level (s*) of each array based on the median absolute deviation of the differences between neighboring probes. A signal above 2s* was considered to be statistically significant (s* is normalized so that it becomes s.d. when the data fit a Gaussian distribution). To identify binding clusters, we first took the mean of the two replicates after rescaling based on their noise levels and applied running median smoothing with a window size of 7 to the mean log ratios along their chromosomal locations. On the basis of the DNA fragment size and the enrichment of the X chromosome compared to 2L, clusters consisting of at least eight probes above the enrichment threshold were counted as significant.
Assembly of nucleosomes and gel-shift assays. We produced MSL3-TAP proteins in baculovirus-infected SF9 cells as previously described, using the 'Bac-to-Bac' expression system (Invitrogen) 8 . Mononucleosomes carrying a specific modification were prepared as described 39 . DNA templates of 216 bp were PCR amplified from the pGEM-601R plasmid using one 5¢-biotinylated primer and one regular primer. Purified DNA probes were reconstituted into nucleosomes with recombinant Xenopus laevis core histones 40 . Resulting mononucleosomes were then immobilized onto streptavidin-coated magnetic Dynal 280 beads and subjected to histone-methylation reactions using human recombinant human Set2 (HYPB) in the presence or absence of 5 mM cold SAM as described previously 41 . Modified nucleosomes were finally released from magnetic beads by overnight incubation with EcoRV. Gel purification of nucleosomes was performed subsequent to release from beads. Electrophoretic mobility shift assay (EMSA) experiments were performed at 30 1C in 15 ml of EMSA buffer (10 mM HEPES, pH 7.8, 50 mM KCl, 4 mM MgCl2, 5 mM DTT, 0.25 mg ml -1 BSA, 5% (v/v) glycerol and 0.1 mM PMSF). The total reactions were directly loaded onto a 3.5-5% native polyacrylamide gel (37.5:1) in 0.3Â TBE. Electrophoresis was carried out at 4 1C for 4-5 h.
Accession codes. Gene Expression Omnibus: ChIP-chip data have been deposited under accession number GSE11817.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
